Ngl Fine-Chem informs about disclosure

18 Jun 2024 Evaluate
Ngl Fine-Chem has informed that the Company has received Certificate of suitability No. CEP 2022-025 - Rev 00, from European Directorate for the Quality of Medicines & Healthcare (EDQM) for its product Triclabendazole. This certificates facilitates registration and use of Triclabendazole manufactured by NGL Fine-Chem by the European customers for their finished product.

The above information is a part of company’s filings submitted to BSE.

NGL Fine-Chem Share Price

1107.40 -22.55 (-2.00%)
04-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1709.40
Dr. Reddys Lab 1109.75
Cipla 1415.55
Lupin 1971.10
Zydus Lifesciences 866.65
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...